【作者】 陈湜；

【导师】 苏海涛；

【作者基本信息】 广州中医药大学 ， 中医学， 2012， 硕士

【摘要】 目的：对患者西医诊断及中医辩证,针对绝经后骨质疏松患者进行干预,研究分析补肾活血法对骨质疏松患者骨代谢指标的影响,分析补肾活血法干预骨代谢生化指标的变化。揭示中医药对绝经后妇女骨质疏松症可能作用机制,并为中医药治疗绝经后妇女骨质疏松提供依据和支持。并为临床治疗提供新选择。方法：按照纳入标准和排除标准标准选取广东省中医院大学城医院骨科2011年6月至2012年2月份住院患者59例,随机分为试验组30例,对照组29例。试验组给予钙尔奇D600mg,qd；骨化三醇0.25ug,bid；骨松安胶囊4片,tid。,对照组单纯给予钙尔奇D600mg,qd；骨化三醇0.25ug,bid；福善美1片70mg,qw,观察两组病例治疗前后ALP、N-MID、PINP、CTX的变化,将相关参数录入数据库。建立SPSS13.0数据库系统,运用统计学软件进行分析,得出结论。结果：1.试验组和对照组治疗前后ALP、N-MID、PINP、CTX各指标有显著性差异(P<0.05),差异有统计学意义。2.试验组和对照组的治疗前ALP、N-MID、PINP、CTX各指标比较无显著性差异(P>0.05),差异无统计学意义。3.试验组和对照组治疗后N-MID、PINP、CTX指标比较有显著性差异(P<0.05),差异有统计学意义；ALP无显著性差异(P>0.05),差异无统计学意义。结论：补肾活血法(骨松安胶囊)治疗绝经后妇女骨质疏松方面可明显抑制破骨作用和促进骨合成,从而改善患者骨质疏松。更多还原

【Abstract】 ObjectivesTo objective the kidney and activating blood on bone metabolism in patiets with postmenopausal osteoporosis.Methods59postmenopausal women with osteoporosis were enrolled, who were randomly divided into2groups according to30:29ratio.the experimental group was given Calcitrio10.25ug、Bone Song-capsule4pills and Catrate D600, the control group was given Calcitrio10.25ug、alendronate sodiumlpill and Caltrate D600. All of the patients were received singe blind treatment for2months.ResultsAt the2th months,the change of bone biochemical markers was significance, resoectively in experimental group and control group.2months later, the PINP in experimental group was decreased40%(P<0.05),CTX in experimental group was decreased52%(p<0.05), N-MID in experimental group was decreased54%(p<0.05), ALP in experimental group was decreased7%(p<0.05). There was no new spine bone fracture in lateral projection of lumbar vertebrate and thoracic vertebrae in two group, While there was no bone fracture in other site. No serious adverse effects were observed during the trial.ConclusionKidney and Activating Blood inhibit bone resorption and increase bone formation. It has less adverse effects. It is a desirable prophylactic and treatment drug of osteoporosis in post menopausal women更多还原